Results 121 to 130 of about 2,247 (156)

Country-Level Canine Leishmaniosis Risk: A Literature Review, 2019-2023. [PDF]

open access: yesZoonoses Public Health
Swisher S   +12 more
europepmc   +1 more source

Co-infection by Leishmania amazonensis and L. infantum/L. chagasi in a case of diffuse cutaneous leishmaniasis in Bolivia.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002
We present the first report of a co-infection by Leishmania amazonensis and L. infantum/L. chagasi isolated in 1993 from a patient with diffuse cutaneous leishmaniasis (DCL), living in the sub-Andean region of Bolivia. This is the third reported case of DCL in Bolivia, but the first one with isoenzymatic identification of the aetiological agents ...
A L Bañuls, M Torrez, F le Pont
exaly   +3 more sources

Evaluation of systemic immunity in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi

Parasite Immunology, 2021
Abstract In some central‐American countries, Leishmania ( L .) infantum chagasi infection can cause non‐ulcerated or atypical cutaneous leishmaniasis (NUCL) in addition to the classic clinical ...
Márcia Dalastra Laurenti   +8 more
openaire   +2 more sources

Leishmania infantum (syn. L. chagasi) parasites affect the release of soluble CD14 by infected macrophages

Parasitology Research, 2021
Functionally, cluster of differentiation 14 (CD14) is a co-receptor of the complex formed by lipopolysaccharide (LPS) and LPS-binding protein expressed on the membrane of a variety of cells. However, CD14 can be shed from the cell membrane into the circulation as soluble CD14 (sCD14) upon cell activation.
Michelle Barreto Gomes, Melo   +8 more
openaire   +2 more sources

Effects of linalool and eugenol on the survival of Leishmania ( L .) infantum chagasi within macrophages

Acta Tropica, 2016
The most commonly used drugs against visceral leishmaniasis are based on pentavalent antimonial compounds, which have played a fundamental role in therapy for over 70 years. However, the treatment is painful and has severe toxic side effects that can be fatal. Antimonial resistance is spreading and reaching alarming proportions.
Fernando L, Dutra   +6 more
openaire   +4 more sources

Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human

Acta Tropica, 2011
Leishmaniasis due to Leishmania infantum (syn. L. chagasi) infection is a zoonotic disease present mainly in Mediterranean basin, central Asia and Brazil. Besides a limited number of human cases of clinical visceral leishmaniasis, a great number of infections remains asymptomatic. In this review, the prevalence of asymptomatic carriers of L.
Grégory, Michel   +3 more
openaire   +2 more sources

Th17 lymphocytes in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi in Central America

Parasite Immunology, 2020
Abstract Skin lesions in nonulcerated cutaneous leishmaniasis (NUCL) caused by Leishmania (L.) infantum chagasi are characterized by a mononuclear inflammatory infiltrate in the dermis, which is composed mainly of lymphocytes, followed by macrophages, few plasma cells and ...
Gabriela Venicia Araujo Flores   +6 more
openaire   +2 more sources

An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi)

The Veterinary Journal, 2014
Canine leishmaniosis caused by Leishmania infantum is still a common disease in endemic areas, such as the Mediterranean countries, and has progressively expanded into non-endemic areas like Central and Northern Europe. The aim of this article is to critically review current knowledge on the diagnosis and treatment of this disease. In dogs with typical
Chiara, Noli   +1 more
openaire   +2 more sources

Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole

Molecular and Cellular Biochemistry, 2013
Drug repositioning has been considered a promising approach to discover novel treatments against neglected diseases. Among the major protozoan diseases, leishmaniasis remains a public health threat with few therapeutic alternatives, affecting 12 million people in 98 countries.
Juliana Tonini, Mesquita   +3 more
openaire   +2 more sources

A prospective study on the dynamics of the clinical and immunological evolution of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010
This prospective study was carried out from October 2003 to December 2005 and involved a cohort of 946 individuals of both genders, aged 1-89 years, from an endemic area for American visceral leishmaniasis (AVL), in Pará State, Brazil. The aim of the study was to analyze the dynamics of the clinical and immunological evolution of human Leishmania (L ...
Fernando T. Silveira   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy